Westbourne Investment Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,130
Closed -$353K 87
2021
Q1
$353K Sell
11,130
-17,595
-61% -$516K 0.18% 64
2020
Q4
$597K Buy
28,725
+2,700
+10% +$50.4K 0.35% 50
2020
Q3
$404K Buy
26,025
+9,180
+54% +$158K 0.46% 34
2020
Q2
$308K Buy
16,845
+3,760
+29% +$66.3K 0.38% 37
2020
Q1
$203K Buy
13,085
+1,100
+9% +$26.5K 0.19% 80
2019
Q4
$359K Buy
+11,985
New +$312K 0.24% 76

Other funds holding BHC

Westbourne Investment Advisors's BHC Position: Q2 2021 in Review

Westbourne Investment Advisors sold out of Bausch Health (BHC) in Q2 2021, closing a stake of 11,130 shares — an estimated $353K sold.

Westbourne Investment Advisors first reported a position in BHC in Q4 2019 and held it in 6 quarters. The position peaked at $597K in Q4 2020. 357 funds tracked by Wall St. Rank hold BHC as of Q2 2021.

  • Westbourne Investment Advisors reported no remaining Bausch Health position as of Q2 2021 after selling out during the quarter.
  • Westbourne Investment Advisors sold 11,130 Bausch Health shares in Q2 2021, an estimated $353K.
  • Westbourne Investment Advisors first reported a position in Bausch Health in Q4 2019 and held it in 6 quarters.
  • Westbourne Investment Advisors's Bausch Health position peaked at $597K in Q4 2020.
  • 357 funds tracked by Wall St. Rank held Bausch Health as of Q2 2021.

Based on Westbourne Investment Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.